|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/22/2024 |
$1.32 |
$1.47 |
$1.32 |
$1.42 |
1.02M | 04/23/2024 |
$1.41 |
$1.51 |
$1.41 |
$1.49 |
1.22M | 04/24/2024 |
$1.48 |
$1.60 |
$1.48 |
$1.50 |
2.34M | 04/25/2024 |
$1.48 |
$1.57 |
$1.45 |
$1.52 |
854.40K | 04/26/2024 |
$1.58 |
$1.60 |
$1.51 |
$1.53 |
896.50K |
|
Atossa Therapeutics is a clinical-stage biopharmaceutical company seeking to develop medicines in areas of oncology and infectious diseases, with a focus on breast cancer, other breast conditions and COVID-19. Co.'s drug under development for breast cancer and other breast conditions is Endoxifen which is being developed primarily in two settings: one to reduce tumor cell activity in breast cancer patients in the neoadjuvant setting, meaning prior to surgery; and another to reduce dense breast tissue in women. Co.'s two COVID-19 drugs under development are: AT-H201, an inhalation therapy for COVID-19 patients; and AT-301, a nasal spray for COVID-19 patients for at-home use. | |
|
Atossa Therapeutics (ATOS) has the following price history information. Looking back at ATOS historical stock prices for the last five trading days, on April 22, 2024, ATOS opened at $1.32, traded as high as $1.47 and as low as $1.32, and closed at $1.42. Trading volume was a total of 1.02M shares. On April 23, 2024, ATOS opened at $1.41, traded as high as $1.51 and as low as $1.41, and closed at $1.49. Trading volume was a total of 1.22M shares. On April 24, 2024, ATOS opened at $1.48, traded as high as $1.60 and as low as $1.48, and closed at $1.50. Trading volume was a total of 2.34M shares. On April 25, 2024, ATOS opened at $1.48, traded as high as $1.57 and as low as $1.45, and closed at $1.52. Trading volume was a total of 854.40K shares. On April 26, 2024, ATOS opened at $1.58, traded as high as $1.60 and as low as $1.51, and closed at $1.53. Trading volume was a total of 896.50K shares.
ATOS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Atossa Therapeutics shares, starting with a $10,000 purchase of ATOS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$221.40 |
|
End price/share: |
$1.53 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.31% |
|
Average Annual Total Return: |
-39.19% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$69.14 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/22/2024 | $1.42 | 04/23/2024 | $1.49 | 04/24/2024 | $1.50 | 04/25/2024 | $1.52 | 04/26/2024 | $1.53 |
|
|